Atlas Trials

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.

Clinical trial NCT02056600 · COMPLETED

Trial details

NCT number
NCT02056600
Sponsor
LG Life Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2014-03-01
Primary completion
2014-04-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.